Pacific Biosciences of California Inc
Change company Symbol lookup
Select an option...
PACB Pacific Biosciences of California Inc
INTC Intel Corp
PSB PS Business Parks Inc
GWRE Guidewire Software Inc
UYM.TC ProShares Ultra Basic Materials ETF
DKS Dick's Sporting Goods Inc
PETZ TDH Holdings Inc
RRC Range Resources Corp
WFC Wells Fargo & Co
HBI HanesBrands Inc
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Closing Price
$13.90
Day's Change
0.125 (0.91%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.91
Day's Low
13.33
Volume
(Light)
Volume:
2,359,738

10-day average volume:
4,980,178
2,359,738

PACB's position in the Life Sciences Tools & Services industry

Industry PeersPACBTXGBNGO

Summary

Company ProfilePacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development...
10x Genomics, Inc. is a life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale...
Go to TXG summary
Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for...
Go to BNGO summary
52-Week Change

VS. INDUSTRY
191.40%
150.39%
-46.89%
Market Cap

VS. INDUSTRY
$2.4B
$14.8B
$74.3M
Beta

VS. INDUSTRY
1.2
--
--
Dividend Yield

VS. INDUSTRY
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
--
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$82.5M
$251.3M
$8.4M
Profit Margin

VS. INDUSTRY
-61.85%
-31.06%
-390.53%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
--
--
Revenue Growth (TTM)

VS. INDUSTRY
4.81%
27.85%
-22.54%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.